A-share biopharmaceutical stocks surged in the short term, with Yiqiao Shenzhou hitting the daily limit. Previously, Nearshore Protein and Baipusaisi had also hit the daily limit, while Novizan, Wufan Biotech, Rongchang Biotech, and Changchun High & New Technology followed suit.